Fig. 2. Prognostic factors for patients with acute myeloid leukemia. (A) OS and (C) EFS in total patients with AML. (B) OS and (D) EFS in patients with CN-AML. (A) Kaplan-Meier survival curves for OS in 142 total patients with AML (P=0.0484) and (B) 61 patients with CN-AML (P=0.0376). (C) EFS curve in total 142 patients with AML (P=0.0012) and (D) EFS curve in 61 patients with CN-AML (P=0.0019).

© Blood Research